Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies. ECN members are chosen by the Board of Directors.
President, Novartis Institutes for BioMedical Research (NIBR)
James (Jay) Bradner, M.D.
President, Innovative Medicines International & Chief Commercial Officer
Marie-France Tschudin
Other Members of Senior Management
President, Global Health and ad interim Chief Strategy & Growth Officer
Lutz Hegemann, M.D., Ph.D.
